Pesquisas alternativas:
cancer spread » cancer ready (Expandir a Pesquisa)
transl lung » transoral lung (Expandir a Pesquisa), transl dunja (Expandir a Pesquisa), cranial lung (Expandir a Pesquisa)
cancer real » cancer renal (Expandir a Pesquisa), cancer reveal (Expandir a Pesquisa), cancer ready (Expandir a Pesquisa)
cancer res » cancer re (Expandir a Pesquisa), cancer read (Expandir a Pesquisa), cancer result (Expandir a Pesquisa)
A mostrar 621 - 640 resultados de 1,002 para a pesquisa 'transl lung ((cancer res) OR (((cancer spread) OR (cancer real))))', tempo de pesquisa: 1.22seg Refinar resultados
Are lung adenocarcinoma mutations shaping the immune microenvironment?
Intraoperative subtyping of lung adenocarcinoma: an unmet need

Professor Fred R. Hirsch: together, our voices are much stronger than individually—a special interview about the 2017 Lung Cancer Awareness Month campaign
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance

Quantitative proteomics analysis of mitochondrial proteins in lung adenocarcinomas and normal lung tissue using iTRAQ and tandem mass spectrometry
Inhibition of AMPK-related kinase 5 (ARK5) enhances cisplatin cytotoxicity in non-small cell lung cancer cells through regulation of epithelial-mesenchymal transition

Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis
INFORM; C-TONG 0805: A multicenter, double blind randomized phase III trial of maintenance gefitinib compared to placebo in advanced non-small cell lung cancer

Is epidermal growth factor receptor tyrosine kinase inhibitor in combination with cytotoxic chemotherapy a better treatment option for patients with EGFR-mutated non-small-cell lung cancer?
Coexistent pulmonary granular cell tumor and adenocarcinoma of the lung

Using Similarity Metrics on Real World Data and Patient Treatment Pathways to Recommend the Next Treatment
Programmed cell death ligand-1 (PD-L1) as a biomarker for non-small cell lung cancer (NSCLC) treatment—are we barking up the wrong tree?

Clear cell adenocarcinoma of the lung: a SEER analysis
Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the “tolerance” to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice

Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer
Do we really care about incidental lung nodules?—Review of atypical lung carcinoid and a proposal for systematic patient follow up

Targeting MET and EGFR in NSCLC—what can we learn from the recently reported phase III trial of onartuzumab in combination with erlotinib in advanced non-small cell lung cancer?
AB047. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors by the EGFR T790M mutation in a non-small cell lung cancer patient in Vietnam

Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy
miR-3940-5p Functions as a Tumor Suppressor in Non–Small Cell Lung Cancer Cells by Targeting Cyclin D1 and Ubiquitin Specific Peptidase-28

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa